DrugPatentWatch Database Preview
CELECOXIB Drug Profile
Email this page to a colleague
When do Celecoxib patents expire, and when can generic versions of Celecoxib launch?
Celecoxib is a drug marketed by Acic Pharms, Alembic Pharms Ltd, Amneal Pharms, Apotex Inc, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Cipla, Cspc Ouyi, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan, Nanjing, Qingdao Baheal Pharm, Sciegen Pharms Inc, Teva, Tianjin Tianyao, Torrent, Umedica Labs Pvt Ltd, Unichem, Watson Labs Inc, and Yiling. and is included in twenty-three NDAs.
The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Celecoxib
A generic version of CELECOXIB was approved as celecoxib by MYLAN on May 30th, 2014.
Summary for CELECOXIB
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 23 |
| Finished Product Suppliers / Packagers: | 47 |
| Raw Ingredient (Bulk) Api Vendors: | 143 |
| Clinical Trials: | 495 |
| Patent Applications: | 4,939 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CELECOXIB |
| Drug Sales Revenues: | Drug sales revenues for CELECOXIB |
| What excipients (inactive ingredients) are in CELECOXIB? | CELECOXIB excipients list |
| DailyMed Link: | CELECOXIB at DailyMed |
Recent Clinical Trials for CELECOXIB
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Imperial College London | Phase 4 |
| The University of Texas Health Science Center, Houston | Phase 4 |
| New York State Psychiatric Institute | Phase 2 |
Pharmacology for CELECOXIB
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for CELECOXIB
ATC Classes for CELECOXIB
US Patents and Regulatory Information for CELECOXIB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umedica Labs Pvt Ltd | CELECOXIB | celecoxib | CAPSULE;ORAL | 210628-003 | Nov 27, 2019 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| Micro Labs | CELECOXIB | celecoxib | CAPSULE;ORAL | 204776-001 | Apr 30, 2018 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| Jubilant Generics | CELECOXIB | celecoxib | CAPSULE;ORAL | 207061-004 | Apr 4, 2017 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| Nanjing | CELECOXIB | celecoxib | CAPSULE;ORAL | 213598-001 | May 13, 2020 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
